Posted on March 22nd, 2010 by
Mutations in the gene could lead to a 'significantly higher risk' of lung cancer among those who have not smoked cigarettes. The research, published in The Lancet Oncology, suggests that targeting the gene could lead to new treatments for the disease, and also identify high risk patients early…
Ping Yang, from the Mayo Clinic College of Medicine, Rochester, USA, led an international team which examined DNA samples from 754 people who had never smoked.
You must be logged-in to the site to post a comment.